LEO LABORATORIES LIMITED

🇮🇪Ireland
Ownership
-
Employees
-
Market Cap
-
Website

Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions

First Posted Date
2015-04-23
Last Posted Date
2017-05-03
Lead Sponsor
LEO Pharma
Target Recruit Count
60
Registration Number
NCT02424305
Locations
🇺🇸

Pflugerville Dermatology Clinical Research, Pflugerville, Texas, United States

PMS to Evaluate the Safety and Efficacy of Picato® Gel

First Posted Date
2015-04-20
Last Posted Date
2019-12-13
Lead Sponsor
LEO Pharma
Target Recruit Count
1324
Registration Number
NCT02421471
Locations
🇰🇷

Department of Dermatology, Korea University Anam Hospital, Seoul, Korea, Republic of

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

First Posted Date
2015-04-14
Last Posted Date
2017-05-03
Lead Sponsor
LEO Pharma
Target Recruit Count
50
Registration Number
NCT02416258
Locations
🇫🇷

Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice, France

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

First Posted Date
2015-04-01
Last Posted Date
2017-05-09
Lead Sponsor
LEO Pharma
Target Recruit Count
502
Registration Number
NCT02406014
Locations
🇩🇪

Gemain, Weber & Craninic, Schweinfurt, Germany

A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

First Posted Date
2015-03-18
Last Posted Date
2017-05-03
Lead Sponsor
LEO Pharma
Target Recruit Count
40
Registration Number
NCT02392130
Locations
🇩🇪

bioskin GmbH, Hamburg, Germany

Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2015-03-13
Last Posted Date
2019-01-15
Lead Sponsor
LEO Pharma
Target Recruit Count
117
Registration Number
NCT02387853
Locations
🇵🇱

MULTIKLINIKA SALUTE Sp zo.o., Katowice, Poland

🇺🇸

Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States

🇺🇸

Redwood Family Dermatology, Santa Rosa, California, United States

and more 6 locations

Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects

First Posted Date
2015-03-05
Last Posted Date
2016-06-14
Lead Sponsor
LEO Pharma
Target Recruit Count
33
Registration Number
NCT02379793
Locations
🇯🇵

Medical Co. LTA HAKATA Clinic, Random Square 5F, 6-18 Tenyamachi, Hakata-ku, Fukuoka, Japan

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

Phase 2
Completed
Conditions
Interventions
First Posted Date
2015-03-04
Last Posted Date
2017-05-03
Lead Sponsor
LEO Pharma
Target Recruit Count
40
Registration Number
NCT02377999
Locations
🇩🇰

Bispebjerg Hospital, Copenhagen NV, Denmark

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

First Posted Date
2015-03-03
Last Posted Date
2017-05-03
Lead Sponsor
LEO Pharma
Target Recruit Count
30
Registration Number
NCT02376049
Locations
🇨🇦

Innovaderm Research Inc., Montreal, Quebec, Canada

🇮🇱

Beit Harofim, Netanya, Israel

The Real Life Topical Field Treatment of Actinic Keratosis Study

First Posted Date
2015-02-12
Last Posted Date
2019-12-13
Lead Sponsor
LEO Pharma
Target Recruit Count
1168
Registration Number
NCT02362152
Locations
🇳🇱

Lievensberg Ziekenhuis, Bergen op Zoom, Netherlands

© Copyright 2024. All Rights Reserved by MedPath